Endocardial fibroelastosis

From WikiMD's Medical Encyclopedia

(Redirected from Fibroelastosis)


Endocardial fibroelastosis
Synonyms EFE
Pronounce N/A
Specialty N/A
Symptoms Heart failure, dyspnea, cyanosis, tachycardia
Complications Heart failure, arrhythmia
Onset Usually in infancy
Duration Chronic
Types N/A
Causes Often unknown, can be associated with viral infection or genetic disorder
Risks Congenital heart defect, family history
Diagnosis Echocardiography, chest X-ray, MRI
Differential diagnosis Dilated cardiomyopathy, restrictive cardiomyopathy
Prevention N/A
Treatment Diuretics, ACE inhibitors, beta blockers, heart transplant
Medication N/A
Prognosis Variable, often poor without treatment
Frequency Rare
Deaths N/A


Endocardial Fibroelastosis is a rare heart condition, typically affecting children and infants. It is characterized by a thickening of the inner lining of the heart chambers due to an increase in the amount of supporting connective tissue and elastic fibers. This condition can lead to heart failure and other complications.

Causes[edit]

The exact cause of Endocardial Fibroelastosis is unknown. However, it is believed to be associated with a viral infection, particularly the Coxsackie B virus. Other potential causes include genetic factors and certain medications.

Symptoms[edit]

Symptoms of Endocardial Fibroelastosis can vary greatly depending on the severity of the condition. Common symptoms include:

  • Shortness of breath
  • Fatigue
  • Rapid heartbeat
  • Swelling in the legs, ankles, and feet

Diagnosis[edit]

Diagnosis of Endocardial Fibroelastosis is typically made through a combination of physical examination, medical history, and diagnostic tests. These tests may include an Echocardiogram, Electrocardiogram, and Cardiac MRI.

Treatment[edit]

Treatment for Endocardial Fibroelastosis is aimed at managing the symptoms and preventing further damage to the heart. This may include medications to help the heart pump more effectively, reduce fluid buildup, and slow the heart rate. In severe cases, a Heart transplant may be necessary.

Prognosis[edit]

The prognosis for individuals with Endocardial Fibroelastosis can vary greatly depending on the severity of the condition and the individual's overall health. With proper treatment and management, many individuals can lead a normal life.

See also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.